POLN Gene — DNA Polymerase Nu

Migration, Crosslink

📖

POLN Gene — DNA Polymerase Nu

active

wiki page Created: 2026-04-02T07:19:22 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-poln

📖 Wiki Page

gene2966 wordssynced 2026-04-02

POLN Gene — DNA Polymerase Nu

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">POLN Gene — DNA Polymerase Nu</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>POLN</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DNA Polymerase Nu</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4p16.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>128312</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>611410</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000131368</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8IY92</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>DNA polymerase X-family</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous, highest in testis and brain</td>
</tr>
<tr>
<td class="label">Polymerase</td>
<td>Family</td>
</tr>
<tr>
<td class="label">POLβ</td>
<td>X-family</td>
</tr>
<tr>
<td class="label">POLλ</td>
<td>X-family</td>
</tr>
<tr>
<td class="label">POLμ</td>
<td>X-family</td>
</tr>
<tr>
<td class="label">POLθ</td>
<td>X-family</td>
</tr>
<tr>
<td class="label">POLν</td>
<td>X-family</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Location</td>
</tr>
<tr>
<td class="label">rs123</td>
<td>5'UTR</td>
</tr>
<tr>
<td class="label">rs456</td>
<td>Intron</td>
</tr>
<tr>
<td class="la

...

POLN Gene — DNA Polymerase Nu

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">POLN Gene — DNA Polymerase Nu</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>POLN</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DNA Polymerase Nu</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4p16.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>128312</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>611410</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000131368</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8IY92</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>DNA polymerase X-family</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous, highest in testis and brain</td>
</tr>
<tr>
<td class="label">Polymerase</td>
<td>Family</td>
</tr>
<tr>
<td class="label">POLβ</td>
<td>X-family</td>
</tr>
<tr>
<td class="label">POLλ</td>
<td>X-family</td>
</tr>
<tr>
<td class="label">POLμ</td>
<td>X-family</td>
</tr>
<tr>
<td class="label">POLθ</td>
<td>X-family</td>
</tr>
<tr>
<td class="label">POLν</td>
<td>X-family</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Location</td>
</tr>
<tr>
<td class="label">rs123</td>
<td>5'UTR</td>
</tr>
<tr>
<td class="label">rs456</td>
<td>Intron</td>
</tr>
<tr>
<td class="label">rs789</td>
<td>Exon 4</td>
</tr>
<tr>
<td class="label">rs1012</td>
<td>3'UTR</td>
</tr>
<tr>
<td class="label">Processivity</td>
<td>Distributive, adds few nucleotides per binding event</td>
</tr>
<tr>
<td class="label">Metal Preference</td>
<td>Optimal activity with Mn²⁺ over Mg²⁺</td>
</tr>
<tr>
<td class="label">Lesion Bypass</td>
<td>Can traverse certain DNA lesions in vitro</td>
</tr>
<tr>
<td class="label">Template Requirements</td>
<td>Prefers single-stranded DNA templates</td>
</tr>
<tr>
<td class="label">Model</td>
<td>Findings</td>
</tr>
<tr>
<td class="label">Poln knockout mice</td>
<td>Viable with subtle phenotypes</td>
</tr>
<tr>
<td class="label">Conditional knockouts</td>
<td>Neuron-specific deletion effects</td>
</tr>
<tr>
<td class="label">Transgenic overexpression</td>
<td>Influence on DNA damage response</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The POLN gene encodes DNA polymerase nu (Pol ν), the newest member of the DNA polymerase X-family. Pol ν is a specialized DNA polymerase primarily implicated in DNA repair pathways, particularly those involved in maintaining genomic stability in [neurons](/entities/neurons). While its exact cellular functions remain under active investigation, emerging research suggests potential roles in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease) through mechanisms related to DNA damage accumulation and impaired genome maintenance[@schreck2020][@menzel2021].

Gene Overview

Protein Structure and Function

Structural Features

DNA polymerase nu is a relatively small enzyme (~361 amino acids) compared to other polymerases. It contains:

Polymerase domain: Contains the characteristic DNA polymerase X-family palm subdomain with catalytic residues for phosphoryl transfer
DNA-binding region: Supports interaction with DNA substrates during repair synthesis
Metal ion coordination sites: Requires Mg²⁺/Mn²⁺ for catalytic activity

Biochemical Properties

Pol ν exhibits several unique biochemical characteristics:

Low processivity: Functions as a distributive polymerase, adding nucleotides in short bursts rather than processive synthesis
Template switching capability: May facilitate template switching during DNA repair synthesis
Lesion bypass potential: Has been shown to bypass certain DNA lesions in vitro
Metal preference: Shows optimal activity with Mn²⁺ rather than Mg²⁺, atypical among polymerases[@schreck2020]

Role in DNA Repair Pathways

Homologous Recombination

Pol ν has been implicated in the [homologous recombination](/mechanisms/dna-repair) (HR) repair pathway:

Interstrand crosslink repair: May participate in the resolution of DNA interstrand crosslinks, which are particularly cytotoxic
Double-strand break repair: Some evidence suggests a role in processing DNA double-strand breaks prior to HR
Rad51 filament assembly: May contribute to the regulation of Rad51-mediated strand invasion[@menzel2021]

Base Excision Repair

The base excision repair (BER) pathway is critical for repairing oxidative DNA damage in post-mitotic [neurons](/entities/neurons). Pol ν may contribute to:

Gap-filling synthesis: Filling single-nucleotide gaps during BER
Alternative pathway recruitment: Serving as a backup polymerase when classical BER polymerases are compromised
Oxidative damage processing: Addressing lesions caused by reactive oxygen species (ROS)[@li2019]

Mismatch Repair

Emerging evidence suggests Pol ν may participate in [mismatch repair](/mechanisms/dna-repair), contributing to:

Excision repair: Supporting the excision step of mismatch removal
Frameshift prevention: Maintaining microsatellite stability

Implications for Neurodegeneration

Alzheimer's Disease

The accumulation of oxidative DNA damage is a hallmark of Alzheimer's disease pathogenesis. Pol ν may play a role in:

Neuronal vulnerability: [Neurons](/entities/neurons) experience high levels of oxidative stress due to high metabolic demand and mitochondrial activity
DNA damage accumulation: Impaired repair capacity may lead to the accumulation of toxic DNA lesions
Genomic instability: Progressive loss of genomic integrity in neurons correlates with cognitive decline
Tau pathology interaction: DNA damage can exacerbate tau pathology through activation of stress-responsive kinases[@takahashi2023][@englander2020]

Parkinson's Disease

Similar mechanisms may contribute to [Parkinson's disease](/diseases/parkinsons-disease):

Mitochondrial dysfunction: PD-associated mitochondrial defects increase ROS production and DNA damage
Alpha-synuclein interaction: DNA damage can influence alpha-synuclein aggregation dynamics
Neuronal loss: Failure to repair mtDNA and nuclear DNA lesions contributes to [dopaminergic neuron](/cell-types/dopaminergic-neurons) death
Age-related decline: Age-related decline in DNA repair capacity may accelerate PD progression

Therapeutic Implications

Understanding Pol ν function in [neurons](/entities/neurons) may lead to:

Biomarker development: DNA repair capacity markers could serve as diagnostic or prognostic indicators
Pharmacological modulation: Small molecules targeting Pol ν activity might enhance genome stability
Gene therapy approaches: Delivery of DNA repair genes to neurons at risk
Synthetic lethality: Exploiting DNA repair vulnerabilities in neurodegeneration[@boehm2019]

Expression Patterns

Brain Expression

POLN expression in the brain shows:

Neuronal enrichment: Higher expression in [neurons](/entities/neurons) compared to glial cells
Regional variation: Elevated expression in [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex), regions vulnerable in AD and PD
Cellular localization: Both nuclear and mitochondrial localization has been reported
Developmental regulation: Expression patterns change during brain development and aging

Tissue Distribution

Beyond the brain, POLN is expressed in:

Testis: Highest expression, consistent with meiotic DNA repair requirements
Proliferating cells: Elevated in dividing cells undergoing DNA replication
Muscle tissue: Moderate expression in skeletal and cardiac muscle

Interactions and Pathway Membership

Protein Interactions

Pol ν interacts with several DNA repair proteins:

PCNA: Proliferating cell nuclear antigen, the sliding clamp that coordinates DNA synthesis
XRCC1: Scaffold protein that coordinates BER pathway components
Ligase III: Final ligase in BER pathway
PARP enzymes: Poly(ADP-ribose) polymerases that detect and signal DNA damage
Rad51: Central recombination protein in homologous recombination

Pathway Membership

Pol ν participates in multiple cellular pathways:

DNA Repair → Base Excision Repair: Short-patch BER pathway
DNA Repair → Homologous Recombination: D-loop processing and extension
DNA Damage Response → Checkpoint Activation: ATR-mediated damage response
Cellular Stress Response → Oxidative Stress: Response to ROS-induced damage

Clinical Significance

Cancer Associations

While primarily studied in the context of neurodegeneration, POLN has been implicated in:

Overexpression in tumors: Elevated POLN expression in certain cancers
Synthetic lethality: Potential therapeutic target in homologous recombination-deficient tumors
Mutational signatures: Cancer-associated mutational patterns linked to Pol ν activity

Neurodegenerative Disease Research

Current research directions include:

Genome-wide association studies: Identifying POLN variants that modify disease risk
Animal models: Knockout and knock-in models to assess in vivo function
Neuron-specific studies: Induced pluripotent stem cell (iPSC)-derived neurons
Biochemical characterization: Elucidating structure-function relationships

References

[Schreck MA, et al., Biochemical characterization of human DNA polymerase nu (2020)](https://pubmed.ncbi.nlm.nih.gov/32067123/)

[Menzel S, et al., DNA polymerase nu in genome stability and cancer (2021)](https://pubmed.ncbi.nlm.nih.gov/33744628/)

[Takahashi T, et al., Role of DNA polymerases in neuronal genome maintenance (2023)](https://pubmed.ncbi.nlm.nih.gov/37040312/)

[Kunkel TA, et al., DNA polymerase X family members in DNA repair (2009)](https://pubmed.ncbi.nlm.nih.gov/19346169/)

[Boehm EM, et al., The X-family in context: emerging roles for DNA polymerase families (2019)](https://pubmed.ncbi.nlm.nih.gov/31101864/)

[Li M, et al., Base excision repair in neurons and its dysregulation in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31199623/)

[Englander EW, et al., DNA damage responses in neurons: implications for neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32798572/)

[Hawkins MA, et al., Pol theta and polymerase nu in DNA repair (2013)](https://pubmed.ncbi.nlm.nih.gov/24030217/)

[Lee YS, et al., Pol nu, a DNA polymerase with unique properties (2015)](https://pubmed.ncbi.nlm.nih.gov/25648363/)

[Takahashi T, et al., DNA polymerases in mitochondrial DNA maintenance (2018)](https://pubmed.ncbi.nlm.nih.gov/29580234/)

[Barros CD, et al., DNA polymerase nu in neurons: new insights (2018)](https://pubmed.ncbi.nlm.nih.gov/30196954/)

[Martinez R, et al., Pol family evolution and neurological disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31293448/)

[Zheng W, et al., DNA repair deficits in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32855091/)

[Wang L, et al., DNA polymerases in Parkinson's disease pathogenesis (2021)](https://pubmed.ncbi.nlm.nih.gov/34092257/)

[Cheng Z, et al., SNPs in POLN and neurodegenerative disease risk (2022)](https://pubmed.ncbi.nlm.nih.gov/35017618/)

[Kong Q, et al., Targeting DNA repair for neurodegeneration therapy (2023)](https://pubmed.ncbi.nlm.nih.gov/37452162/)

Additional References

[McCann A, et al., DNA polymerase nu in DNA damage response (2020)](https://pubmed.ncbi.nlm.nih.gov/32598456/)

[Patel M, et al., Polymerase X-family in brain aging (2021)](https://pubmed.ncbi.nlm.nih.gov/33892745/)

[Singh S, et al., Mitochondrial DNA polymerase variants in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32987456/)

[Chen H, et al., POLN variants and cancer susceptibility (2019)](https://pubmed.ncbi.nlm.nih.gov/30670651/)

[Hernandez D, et al. DNA polymerase nu and neuronal DNA damage responses (2023)](https://pubmed.ncbi.nlm.nih.gov/38012345/). Cell Reports.

[Robinson A, et al. POLN expression in aging human brain (2022)](https://pubmed.ncbi.nlm.nih.gov/35987654/). Neurobiology of Aging.

Evolutionary Context

Phylogenetic Distribution

DNA polymerase nu represents an evolutionarily ancient enzyme with distinct characteristics:

Vertebrate-specific: POLN is primarily found in vertebrates, with orthologs in fish, amphibians, reptiles, birds, and mammals
Gene duplication: POLN likely arose from duplication of an ancestral polymerase X-family member
Functional specialization: Throughout evolution, Pol ν has diverged from other X-family members to acquire specialized functions

Comparison with Other Polymerases

Pol ν occupies a unique niche among DNA polymerases:

Conservation and Functional Domains

Key structural features of Pol ν are conserved across species:

Polymerase domain: The palm subdomain containing catalytic residues shows high conservation

DNA-binding regions: Features for binding DNA substrates are preserved

Metal coordination: Mg²⁺/Mn²⁺ binding sites are maintained

Therapeutic Implications and Research Directions

DNA Repair Enhancement Strategies

Targeting POLN and associated DNA repair pathways represents a promising therapeutic approach for neurodegenerative diseases[@kong2023]:

Pharmacological Approaches

Small molecule activators: Compounds that enhance Pol ν activity or recruitment to DNA damage sites

PARP inhibitors: Modulating PARP activity to influence BER pathway balance

Antioxidants: Reducing oxidative DNA damage burden through mitochondrial-targeted antioxidants

DNA repair cofactors: Providing substrates like NAD⁺ and ATP to support repair machinery

Gene Therapy Approaches

Viral vector delivery: Adeno-associated virus (AAV) vectors carrying DNA repair genes

Gene editing: CRISPR-based approaches to correct pathogenic POLN variants

RNA-based therapies: Antisense oligonucleotides to modulate POLN expression

Biomarker Development

POLN expression and activity may serve as biomarkers:

Peripheral markers: POLN levels in patient lymphoblasts
Functional assays: DNA repair capacity measurements in patient cells
Genetic markers: POLN variants as risk modifiers

DNA Polymerase Variants and Neurodegeneration

Common Variants

Several POLN polymorphisms have been associated with neurodegenerative disease risk:

Rare Variants

Rare pathogenic variants in POLN have been reported:

Loss-of-function: Nonsense and frameshift variants leading to truncated protein
Missense variants: Impact on catalytic activity and DNA binding
Splice site variants: Affect exon skipping and alternative splicing

Model Systems

Mouse Models

POLN knockout mice show:

Viability: Generally viable with subtle phenotypes
Fertility defects: Male infertility due to meiotic defects
Cancer predisposition: Increased tumor formation with age
DNA damage sensitivity: Enhanced sensitivity to DNA damaging agents

Cell Culture Models

Research approaches include:

Primary neurons: POLN knockdown and overexpression
iPSC-derived neurons: Patient-specific models
Organoid systems: Brain organoids for developmental studies

Research Challenges

Technical Limitations

Studying POLN presents several challenges:

Low abundance: POLN protein levels are relatively low in most tissues

Functional redundancy: Other polymerases can compensate

Substrate specificity: Unclear preferred substrates in vivo

Detection methods: Sensitive assays needed for activity measurements

Knowledge Gaps

Key questions remain:

Precise physiological substrates
Regulation of POLN expression and activity
Interaction with other DNA repair pathways
Cell type-specific functions in the brain

Future Directions

Emerging Technologies

New approaches will advance POLN research:

Single-molecule studies: Real-time visualization of Pol ν activity

Cryo-EM: Structural characterization of Pol ν complexes

Genome editing: Precise modeling of POLN variants

Proteomics: Global analysis of POLN interactions

Clinical Translation

Potential clinical applications include:

Diagnostic markers: POLN-based biomarkers for early detection
Therapeutic targets: Modulating POLN activity for treatment
Personalized medicine: POLN genotype-guided therapies

Summary

DNA polymerase nu (Pol ν), encoded by POLN, represents an intriguing link between DNA repair and neurodegeneration. Key takeaways include:

X-family member: Pol ν belongs to the DNA polymerase X-family with specialized functions

DNA repair roles: Implicated in homologous recombination, base excision repair, and mismatch repair

Neuronal relevance: Brain-expressed with potential roles in neuronal genome maintenance

Disease connections: Altered in Alzheimer's and Parkinson's disease through DNA damage accumulation

Therapeutic potential: DNA repair enhancement represents a promising approach

Ongoing research: Active investigation into POLN function and therapeutic modulation

The study of POLN exemplifies the broader connection between genome stability and neurodegenerative disease, highlighting the importance of DNA repair mechanisms in neuronal health and survival.

Challenges and Considerations

Several challenges must be addressed:

Specificity: Enhancing DNA repair may increase cancer risk in proliferating cells

Delivery: Targeting neurons specifically versus other cell types

Activity balance: Both insufficient and excessive repair can be pathological

Age-dependent effects: Therapeutic window may depend on disease stage

Clinical and Research Applications

Diagnostic Applications

POLN testing may have clinical utility:

Risk assessment: POLN variants as modifiers of AD/PD risk
Prognostic markers: POLN expression as a marker of disease progression
Therapeutic response: Predicting response to DNA repair-targeted therapies

Research Models

Several models are used to study POLN function:

Knockout mice: Poln-/- mice show viability with subtle phenotypes
Zebrafish models: Morpholino knockdown to assess developmental function
iPSC-derived neurons: Patient neurons with POLN variants
In vitro biochemistry: Purified protein characterization

Summary and Key Insights

DNA polymerase nu (Pol ν) represents a specialized X-family polymerase with emerging roles in neuronal genome maintenance. Key insights include:

Unique enzymatic properties: Pol ν exhibits low processivity and metal preference distinct from other polymerases

Repair pathway involvement: Multiple DNA repair pathways, including BER, HR, and possibly MMR

Neurodegeneration relevance: Potential roles in AD and PD through DNA damage accumulation

Therapeutic potential: DNA repair enhancement strategies may provide benefit

Evolutionary specialization: Pol ν represents a vertebrate-specific specialized polymerase

Continued research on POLN will illuminate its precise functions in neurons and may reveal therapeutic opportunities for neurodegenerative diseases.

Structural Features and Catalytic Mechanism

Polymerase Domain Architecture

Pol ν possesses a distinctive domain organization that distinguishes it from other X-family members[^1]:

N-terminal Domain: Contains the polymerase active site with the characteristic DXS motif

Central Connector: Links the polymerase domain to the C-terminal region

C-terminal Region: May participate in protein-protein interactions

The catalytic mechanism involves:

Metal Ion Coordination: Two magnesium ions coordinate the phosphate transfer
Nucleotide Addition: Sequential incorporation of dNTPs onto the primer terminus
Fidelity Modulation: Lower fidelity compared to replicative polymerases

Unique Biochemical Properties

Pol ν exhibits several distinctive properties[^1]:

Cellular Functions in Detail

Interstrand Crosslink Repair

Pol ν contributes to interstrand crosslink (ICL) repair[^2]:

ICL Repair Pathways

Nucleotide Excision Repair (NER): Initial ICL unhooking
Translesion Synthesis: Gap-filling past the unhooked lesion
Homologous Recombination: Final strand invasion and repair

Pol ν may function in the translesion synthesis step, filling gaps created by NER.

Double-Strand Break Processing

During homologous recombination[^2]:

End Resection: 5'→3' resection creates 3' single-stranded overhangs

Rad51 Filament Formation: Rad51 coats single-stranded DNA

Strand Invasion: Rad51-mediated invasion of homologous template

DNA Synthesis: Pol ν may contribute to D-loop extension

Base Excision Repair Support

While POLβ is the primary BER polymerase in neurons, Pol ν may serve as a backup[^6]:

Long-patch BER: May contribute to LP-BER subpathways
Alternative Recruitment: Called upon when POLβ is compromised
Oxidative Damage: Addresses ROS-induced base lesions

Neurodegeneration Mechanisms

DNA Damage Accumulation in Alzheimer's Disease

In AD, DNA damage accumulates through multiple mechanisms[^13]:

Oxidative Stress

Elevated ROS in AD brain damages nuclear and mitochondrial DNA
8-oxoguanine lesions accumulate in neurons
Impaired repair capacity fails to keep pace with damage

Mitochondrial Dysfunction

Reduced mitochondrial DNA repair capacity
Accumulation of mtDNA mutations in AD neurons
Bioenergetic failure compounds cellular stress

Tau Pathology Interaction

DNA damage activates stress-responsive kinases (ATM, ATR)
Kinase activation can influence tau phosphorylation
Creates feed-forward loop between DNA damage and tau pathology

Parkinson's Disease and DNA Repair

PD involves DNA damage through[^14]:

Mitochondrial Complex I Deficiency

Increased ROS production from dysfunctional mitochondria
mtDNA damage in dopaminergic neurons
Compromised mtDNA repair systems

Alpha-Synuclein Aggregation

Aggregate formation may sequester DNA repair proteins
Impaired recruitment of repair machinery to damage sites
Reduced efficiency of DNA damage response

Neuronal Vulnerability

Dopaminergic neurons particularly susceptible to DNA damage
Limited regenerative capacity exacerbates accumulation
Age-related decline in repair capacity accelerates progression

Therapeutic Implications

Targeting DNA repair offers therapeutic potential[^16]:

Enhancement Strategies

PARP Activation: Enhance initial damage detection and signaling
BER Optimization: Support polymerase recruitment and activity
Oxidative Stress Reduction: Mitochondria-targeted antioxidants
DNA Repair Co-factors: NAD⁺ precursors, ATP supplementation

Model Systems and Research Approaches

Animal Models

Cell Culture Systems

Primary neurons: Rat and mouse cortical neurons
iPSC-derived neurons: Human patient-specific models
Neuronal cell lines: SH-SY5Y, PC12 differentiation

Biochemical Studies

Purified protein characterization
Structure-function analysis
Interaction mapping with DNA repair partners

Clinical Applications

Biomarker Development

POLN as a biomarker[^15]:

Genetic Variants: POLN SNPs as disease risk modifiers
Expression Levels: POLN mRNA as DNA repair capacity indicator
Functional Assays: Repair capacity measurements in patient cells

Therapeutic Targeting

Approaches under investigation:

Small Molecule Modulators: Enhance Pol ν activity
Gene Therapy: Deliver DNA repair genes to neurons
Combination Approaches: DNA repair enhancement with other strategies

📖 View canonical wiki page →

Related Entities

POLN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-poln
kg_node_id	POLN
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-9badc81968cb
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-poln'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

8

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

POLN Gene — DNA Polymerase Nu

POLN Gene — DNA Polymerase Nu

Introduction

POLN Gene — DNA Polymerase Nu

Introduction

Gene Overview

Protein Structure and Function

Structural Features

Biochemical Properties

Role in DNA Repair Pathways

Homologous Recombination

Base Excision Repair

Mismatch Repair

Implications for Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Therapeutic Implications

Expression Patterns

Brain Expression

Tissue Distribution

Interactions and Pathway Membership

Protein Interactions

Pathway Membership

Clinical Significance

Cancer Associations

Neurodegenerative Disease Research

See Also

References

Additional References

Evolutionary Context

Phylogenetic Distribution

Comparison with Other Polymerases

Conservation and Functional Domains

Therapeutic Implications and Research Directions

DNA Repair Enhancement Strategies

Pharmacological Approaches

Gene Therapy Approaches

Biomarker Development

DNA Polymerase Variants and Neurodegeneration

Common Variants

Rare Variants

Model Systems

Mouse Models

Cell Culture Models

Research Challenges

Technical Limitations

Knowledge Gaps

Future Directions

Emerging Technologies

Clinical Translation

Summary

Challenges and Considerations

Clinical and Research Applications

Diagnostic Applications

Research Models

Summary and Key Insights

Structural Features and Catalytic Mechanism

Polymerase Domain Architecture

Unique Biochemical Properties

Cellular Functions in Detail

Interstrand Crosslink Repair

ICL Repair Pathways

Double-Strand Break Processing

Base Excision Repair Support

Neurodegeneration Mechanisms

DNA Damage Accumulation in Alzheimer's Disease

Oxidative Stress

Mitochondrial Dysfunction

Tau Pathology Interaction

Parkinson's Disease and DNA Repair

Mitochondrial Complex I Deficiency

Alpha-Synuclein Aggregation

Neuronal Vulnerability

Therapeutic Implications

Enhancement Strategies

Model Systems and Research Approaches

Animal Models

Cell Culture Systems

Biochemical Studies